Minari Capital

A private family office dedicated to long-term value creation through disciplined investment strategy and strategic partnerships. We seek to collaborate with exceptional founders, managers, and institutional partners aligned with our investment philosophy.

Our Family Office

Strategic Capital Deployment

Founded in 2025, Minari Capital represents our family's consolidated investment vehicle dedicated to identifying and supporting transformative opportunities in technology and innovation. We focus on sustainable value creation through strategic investments in emerging sectors.

Our approach combines institutional rigor with the agility and long-term perspective unique to family offices. We partner selectively with world-class teams and maintain a patient investment philosophy aligned with our core focus areas.

Investment Approach

Core Investment Themes

We focus on sectors aligned with long-term growth trends, supported by rigorous analysis and deep sector expertise.

Semiconductors & Chips
Strategic investments in semiconductor manufacturers, chip design, and advanced semiconductor technologies powering next-generation computing.
Chip DesignSemiconductor FabsAdvanced PackagingSemiconductor Equipment
Robotics & Automation
Deep investments in robotics, industrial automation, and autonomous systems transforming manufacturing, logistics, and service industries.
Industrial RoboticsAutonomous SystemsRobotic Process AutomationManufacturing Tech
AI & Software Innovation
Investments in artificial intelligence, machine learning platforms, and enterprise software enabling intelligent automation and decision-making.
AI PlatformsMachine LearningEnterprise SoftwareData Intelligence
Emerging Tech & Infrastructure
Forward-looking allocations to quantum computing, advanced materials, edge computing, and the infrastructure supporting technological advancement.
Quantum ComputingAdvanced MaterialsEdge ComputingDigital Assets & Blockchain Technology
Space & Infrastructure
Strategic investments in commercial space infrastructure, satellite technologies, and space-based services enabling the next generation of global connectivity and manufacturing.
Commercial Space StationsSatellite TechnologySpace LaunchSpace-based Manufacturing
Biotech & Life Sciences
Strategic investments in biotechnology, genomics, therapeutics, and life sciences innovations addressing critical healthcare and biological challenges.
GenomicsTherapeutic InnovationLife Sciences ToolsHealthcare Technology

Latest Deals

Recent Investments

Our most recent strategic investments in next-generation technology.

Actinide

The Scalable American Isotope Separation Platform Ending Russian Dependence

Deep TechDefenseNuclearRadiopharmaceuticals

Actinide is building the scalable, American-owned isotope separation platform producing atomically pure substances that ends U.S. dependence on Russian supply, unlocking explosive growth in radiopharmaceuticals, nuclear, defense, and advanced materials.

The company has modernized calutron technology—originally developed during the Manhattan Project—enabling production of atomically pure materials at a cost and speed previously thought impossible. Instead of legacy designs, Actinide rebuilt the system with modern physics simulation tools, advanced magnet assemblies, semiconductor-grade components, and in-house manufacturing. The result: turning $2/g materials into $36,000/g isotopes.

Why We Invested

  • Critical Supply Chain Gap: Almost all high-value isotopes come from Rosatom in Russia. Actinide is the only private U.S. company capable of producing these materials at commercial scale, creating a near-monopoly opportunity.
  • Massive Market Opportunity: The radiopharmaceutical market is $12B+ in 2025 and growing >30% CAGR. 90+ active treatment trials depend on isotopes Actinide can supply. Defense and semiconductor markets represent additional multi-billion dollar opportunities.
  • Strong Traction: First machine operational with third-party verified product. Closed $7.2M supply agreement with a publicly traded radiopharmaceutical company and supply contract with Oklo ($13B nuclear company).
  • Exceptional Founders: Eric Olszewski (CEO) is a repeat founder and early Ethereum developer who invested $1M+ of his own capital. Robert Mendelsohn (CTO) spent 7 years building isotope separators and twice won Wolfram Research's programming championship.

Investment Terms

Our Investment

$400K

Round Size

$5M

Pre-Money Valuation

$25M (Post-Money SAFE)

Round Type

Seed

Use of Funds

  • • Build five additional isotope-separation machines
  • • Hire machinist/metallurgist and systems control engineer
  • • Add machine operators for continuous production
  • • Upgrade internal machine shop and secure larger facility
Showing 1 of 7 recent investments

OUR INVESTMENTS

Portfolio Highlights

A selection of our strategic investments across semiconductors, robotics, AI, digital assets, and emerging technologies.

Emerging Tech & Infrastructure

Actinide

Actinide is building the scalable, American-owned isotope separation platform that ends U.S. dependence on Russian supply. By modernizing Manhattan Project-era calutron technology with modern simulation and semiconductor-grade components, Actinide produces atomically pure materials for radiopharmaceuticals, nuclear, defense, and advanced materials markets.

Semiconductors & Chips

Oxmiq Labs

Oxmiq Labs is rearchitecting the GPU full stack from 'Atoms to Agents' for next-generation multimodal AI. Led by Raja Koduri, a 25-year GPU veteran (ex-Intel, AMD, Apple), the company is building a unified GPU architecture that scales from edge AI to zetta-scale data centers. Backed by Intel, MediaTek, and Tenstorrent's Jim Keller.

Showing 1–2 of 32 investments

Get in Touch

Start a Conversation

We welcome inquiries from potential partners, founders, and institutional collaborators.

Send Inquiry
Tell us about your opportunity or partnership proposal